Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience - Khunger, A; Khunger, M; Velcheti, V (Ther Adv Respir Dis, 2018)